Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade for Severe IgA Nephropathy
NCT01103778Phase 4Completed
- Sponsor
- Rogosin Institute
- Start
- Jul 2010
- Primary completion
- Apr 2017
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of bortezomib in IgA nephropathy (IgAN), sponsored by Rogosin Institute. Started Jul 2010; status: completed.
02
Drugs
bortezomib
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT01103778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01103778.